Picture of International Biotechnology Trust logo

IBT International Biotechnology Trust News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsConservativeSmall Cap

REG - Intnl. Biotechnology - Net Asset Value(s)

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240322:nRSV9773Ha&default-theme=true

RNS Number : 9773H  Intl. Biotechnology Trust PLC  22 March 2024

 

 

International Biotechnology Trust plc

Net Asset Values

 

The Board of Schroder International Biotech Trust PLC (the "Company")
announces the unaudited net asset value ("NAV") per share of the Company as
follows:

 

 

 Date             NAV         Pence
 Thursday 21 Mar  Ex Income   741.59
 Thursday 21 Mar  Cum Income  734.98

 

 

The above NAVs have been calculated in accordance with the recommendations of
the Association of Investment Companies.

 

 

 

22-Mar-2024

 

 

 

 

Enquiries:

International Biotechnology Trust plc

Schroder Investment Management Limited

Company Secretary 0207 658 6501

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NAVPPUQPWUPCGUP

Recent news on International Biotechnology Trust

See all news